U.S. Gout Therapeutics Market Dynamics: Key Drivers, Restraints, and Opportunities
The U.S. gout therapeutics market, valued at USD 1.40 billion in 2024, is projected to grow at a compound annual growth rate (CAGR) of 6.9% from 2025 to 2034, driven by rising prevalence of hyperuricemia, increasing obesity rates, and growing awareness of chronic gout as a progressive inflammatory disease rather than an episodic condition. Gout—a form of inflammatory arthritis caused by...
0 Reacties 0 aandelen 46 Views 0 voorbeeld